Skip to main content
Erschienen in: Metabolic Brain Disease 2/2013

01.06.2013 | Original Paper

Update on cerebral uptake of blood ammonia

verfasst von: Michael Sørensen

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Ammonia is believed to play a key role in the development of hepatic encephalopathy (HE) with increased formation of glutamine playing a central role. It has been debated whether blood ammonia enters the brain by passive diffusion and/or active transport by ion-transporters and that changes in blood pH could affect the blood-to-brain transfer of ammonia. It has also been proposed that the permeability-surface area product for ammonia across the blood–brain barrier (PSBBB) should be increased in cirrhosis and HE. In the present paper it is argued that changes in blood pH does not alter PSBBB for ammonia and the question of passive diffusion versus active transport of ammonia remains unresolved. Furthermore, recent studies do not find evidence for increased PSBBB for ammonia in cirrhosis. The main determent for cerebral uptake of blood ammonia (i.e. flux) is the arterial blood ammonia concentration. This means that the only way to protect the brain from hyperammonemia is by lowering blood ammonia, inhibit cerebral uptake of ammonia, or by manipulating cerebral ammonia metabolism so that less glutamine is produced.
Fußnoten
1
13N-ammonia refers to the sum of 13NH3 and 13NH4 + because the two cannot be separated in PET studies.
 
Literatur
Zurück zum Zitat Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef
Zurück zum Zitat Bhatia V, Singh R, Acharya SK (2006) Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55:98–104PubMedCrossRef Bhatia V, Singh R, Acharya SK (2006) Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55:98–104PubMedCrossRef
Zurück zum Zitat Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29:648–653PubMedCrossRef Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P (1999) Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29:648–653PubMedCrossRef
Zurück zum Zitat Cooper AJ (2012) Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase. Metab Brain Dis [Epub ahead of print] Cooper AJ (2012) Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase. Metab Brain Dis [Epub ahead of print]
Zurück zum Zitat Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE (1979) The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254:4982–4992PubMed Cooper AJ, McDonald JM, Gelbard AS, Gledhill RF, Duffy TE (1979) The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 254:4982–4992PubMed
Zurück zum Zitat Crone C (1963) The permeability of capillaries in various organs as determined as by use of the ‘indicator diffusion’ method. Acta Physiol Scand 58:292–305PubMedCrossRef Crone C (1963) The permeability of capillaries in various organs as determined as by use of the ‘indicator diffusion’ method. Acta Physiol Scand 58:292–305PubMedCrossRef
Zurück zum Zitat Dadsetan S, Bak LK, Sørensen M, Keiding S, Vilstrup H, Ott P, Leke R, Schousboe A, Waagepetersen HS (2011) Inhibition of glutamine synthesis induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons. Neurochem Int 59:482–488PubMedCrossRef Dadsetan S, Bak LK, Sørensen M, Keiding S, Vilstrup H, Ott P, Leke R, Schousboe A, Waagepetersen HS (2011) Inhibition of glutamine synthesis induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons. Neurochem Int 59:482–488PubMedCrossRef
Zurück zum Zitat Dam G, Keiding S, Munk OL, Ott P, Vilstrup H, Bak LK, Waagepetersen HS, Schousboe A, Sørensen M (2012) Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. Hepatology [Epub ahead of print] Dam G, Keiding S, Munk OL, Ott P, Vilstrup H, Bak LK, Waagepetersen HS, Schousboe A, Sørensen M (2012) Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. Hepatology [Epub ahead of print]
Zurück zum Zitat Gershoff SN, Elvehjem CA (1951) The relative effect of methionine sulfoximine on different animal species. J Nutr 45:451–458PubMed Gershoff SN, Elvehjem CA (1951) The relative effect of methionine sulfoximine on different animal species. J Nutr 45:451–458PubMed
Zurück zum Zitat Goldbecker A, Buchert R, Berding G, Bokemeyer M, Lichtinghagen R, Wilke F, Ahl B, Weissenborn K (2010) Blood–brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls. J Cereb Blood Flow Metab 30:1384–1393PubMedCrossRef Goldbecker A, Buchert R, Berding G, Bokemeyer M, Lichtinghagen R, Wilke F, Ahl B, Weissenborn K (2010) Blood–brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls. J Cereb Blood Flow Metab 30:1384–1393PubMedCrossRef
Zurück zum Zitat Iversen P, Sørensen M, Bak LK, Waagepetersen HS, Vafaee MS, Borghammer P, Mouridsen K, Jensen SB, Vilstrup H, Schousboe A, Ott P, Gjedde A, Keiding S (2009) Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 136:863–871PubMedCrossRef Iversen P, Sørensen M, Bak LK, Waagepetersen HS, Vafaee MS, Borghammer P, Mouridsen K, Jensen SB, Vilstrup H, Schousboe A, Ott P, Gjedde A, Keiding S (2009) Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 136:863–871PubMedCrossRef
Zurück zum Zitat Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 44:42–50, Erratum in: Hepatology 2006;44:1056CrossRef Keiding S, Sørensen M, Bender D, Munk OL, Ott P, Vilstrup H (2006) Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 44:42–50, Erratum in: Hepatology 2006;44:1056CrossRef
Zurück zum Zitat Kety SS (1951) The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3:1–41PubMed Kety SS (1951) The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3:1–41PubMed
Zurück zum Zitat Leke R, Bak LK, Anker M, Melø TM, Sørensen M, Keiding S, Vilstrup H, Ott P, Portela LV, Sonnewald U, Schousboe A, Waagepetersen HS (2011) Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine. Neurotox Res 19:496–510PubMedCrossRef Leke R, Bak LK, Anker M, Melø TM, Sørensen M, Keiding S, Vilstrup H, Ott P, Portela LV, Sonnewald U, Schousboe A, Waagepetersen HS (2011) Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine. Neurotox Res 19:496–510PubMedCrossRef
Zurück zum Zitat Norenberg MD, Martinez-Hernandez A (1979) Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161:303–310PubMedCrossRef Norenberg MD, Martinez-Hernandez A (1979) Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161:303–310PubMedCrossRef
Zurück zum Zitat Ong JP, Aggarwall A, Krieger D, Easley KA, Karafa MT, van Lente F, Arroliga AC, Mullen KD (2003) Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 114:188–193PubMedCrossRef Ong JP, Aggarwall A, Krieger D, Easley KA, Karafa MT, van Lente F, Arroliga AC, Mullen KD (2003) Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 114:188–193PubMedCrossRef
Zurück zum Zitat Ott P, Larsen FS (2004) Blood–brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 44:185–198PubMedCrossRef Ott P, Larsen FS (2004) Blood–brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 44:185–198PubMedCrossRef
Zurück zum Zitat Phelps ME, Hoffman EJ, Raybaud C (1977) Factors which affect cerebral uptake and retention of 13NH3. Stroke 8:694–702PubMedCrossRef Phelps ME, Hoffman EJ, Raybaud C (1977) Factors which affect cerebral uptake and retention of 13NH3. Stroke 8:694–702PubMedCrossRef
Zurück zum Zitat Phelps ME, Huang SC, Hoffman EJ, Selin C, Kuhl DE (1981) Cerebral extraction of N-13 ammonia: its dependence on cerebral blood flow and capillary permeability-surface area product. Stroke 12:607–619PubMedCrossRef Phelps ME, Huang SC, Hoffman EJ, Selin C, Kuhl DE (1981) Cerebral extraction of N-13 ammonia: its dependence on cerebral blood flow and capillary permeability-surface area product. Stroke 12:607–619PubMedCrossRef
Zurück zum Zitat Raichle ME, Larson KB (1981) The significance of the NH3-NH4 + equilibrium on the passage of 13N-ammonia from blood to brain. A new regional residue detection model. Circ Res 48:913–937PubMedCrossRef Raichle ME, Larson KB (1981) The significance of the NH3-NH4 + equilibrium on the passage of 13N-ammonia from blood to brain. A new regional residue detection model. Circ Res 48:913–937PubMedCrossRef
Zurück zum Zitat Rama Rao KV, Norenberg MD (2012) Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int 60:697–706PubMedCrossRef Rama Rao KV, Norenberg MD (2012) Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int 60:697–706PubMedCrossRef
Zurück zum Zitat Rama Rao KV, Jayakumar AR, Norenberg MD (2012) Glutamine in the pathogenesis of acute hepatic encephalopathy. Neurochem Int 61:575–580PubMedCrossRef Rama Rao KV, Jayakumar AR, Norenberg MD (2012) Glutamine in the pathogenesis of acute hepatic encephalopathy. Neurochem Int 61:575–580PubMedCrossRef
Zurück zum Zitat Renkin EM (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197:1205–1210PubMed Renkin EM (1959) Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 197:1205–1210PubMed
Zurück zum Zitat Sørensen M, Keiding S (2007) New findings on cerebral ammonia uptake in HE using functional 13N-ammonia PET. Metab Brain Dis 22:277–284PubMedCrossRef Sørensen M, Keiding S (2007) New findings on cerebral ammonia uptake in HE using functional 13N-ammonia PET. Metab Brain Dis 22:277–284PubMedCrossRef
Zurück zum Zitat Sørensen M, Ott P (2012) Cerebral Ammonia Metabolism in Cirrhosis. In Keiding S, Sørensen M (eds) Functional Molecular Imaging in Hepatology. Bentham e-books, pp 153–159 Sørensen M, Ott P (2012) Cerebral Ammonia Metabolism in Cirrhosis. In Keiding S, Sørensen M (eds) Functional Molecular Imaging in Hepatology. Bentham e-books, pp 153–159
Zurück zum Zitat Sørensen M, Munk OL, Keiding S (2009) Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathy. Metab Brain Dis 24:237–242PubMedCrossRef Sørensen M, Munk OL, Keiding S (2009) Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathy. Metab Brain Dis 24:237–242PubMedCrossRef
Zurück zum Zitat Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jørgensen L, Larsen FS (2006) Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 26:21–27PubMedCrossRef Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jørgensen L, Larsen FS (2006) Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 26:21–27PubMedCrossRef
Zurück zum Zitat Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H (2007) Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 56:1736–1742PubMedCrossRef Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H (2007) Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 56:1736–1742PubMedCrossRef
Metadaten
Titel
Update on cerebral uptake of blood ammonia
verfasst von
Michael Sørensen
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2013
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-013-9395-1

Weitere Artikel der Ausgabe 2/2013

Metabolic Brain Disease 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.